Identification of disease comorbidity through hidden molecular mechanisms.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 27991583)

Published in Sci Rep on December 19, 2016

Authors

Younhee Ko1, Minah Cho2, Jin-Sung Lee1, Jaebum Kim2

Author Affiliations

1: Department of Clinical Genetics, Department of Pediatrics, Yonsei University College of Medicine, Seoul 03722, South Korea.
2: Department of Stem Cell and Regenerative Biology, Konkuk University, Seoul 05029, South Korea.

Articles cited by this

Network biology: understanding the cell's functional organization. Nat Rev Genet (2004) 36.62

The human disease network. Proc Natl Acad Sci U S A (2007) 19.58

STRING v9.1: protein-protein interaction networks, with increased coverage and integration. Nucleic Acids Res (2012) 18.26

The genetic association database. Nat Genet (2004) 11.29

Tumor metastasis: molecular insights and evolving paradigms. Cell (2011) 10.34

Disease Ontology: a backbone for disease semantic integration. Nucleic Acids Res (2011) 6.03

Defining comorbidity: implications for understanding health and health services. Ann Fam Med (2009) 5.78

The Human Phenotype Ontology project: linking molecular biology and disease through phenotype data. Nucleic Acids Res (2013) 5.66

Human disease classification in the postgenomic era: a complex systems approach to human pathobiology. Mol Syst Biol (2007) 5.02

Prioritizing candidate disease genes by network-based boosting of genome-wide association data. Genome Res (2011) 4.39

The BioGRID interaction database: 2015 update. Nucleic Acids Res (2014) 4.06

Effect of age, tumor risk, and comorbidity on competing risks for survival in a U.S. population-based cohort of men with prostate cancer. Ann Intern Med (2013) 3.74

A dynamic network approach for the study of human phenotypes. PLoS Comput Biol (2009) 3.62

The implications of human metabolic network topology for disease comorbidity. Proc Natl Acad Sci U S A (2008) 3.41

Network properties of genes harboring inherited disease mutations. Proc Natl Acad Sci U S A (2008) 3.37

Comorbidity: a network perspective. Behav Brain Sci (2010) 2.89

Tumor metastasis: moving new biological insights into the clinic. Nat Med (2013) 2.71

The impact of cellular networks on disease comorbidity. Mol Syst Biol (2009) 2.23

Disease networks. Uncovering disease-disease relationships through the incomplete interactome. Science (2015) 1.95

EnrichNet: network-based gene set enrichment analysis. Bioinformatics (2012) 1.92

The impact of comorbidity on cancer survival: a review. Clin Epidemiol (2013) 1.68

Biological impacts and context of network theory. J Exp Biol (2007) 1.54

Human symptoms-disease network. Nat Commun (2014) 1.36

Comorbid disease and cancer: the need for more relevant conceptual models in health services research. J Clin Oncol (2005) 1.26

Influence of comorbidity on survival, toxicity and health-related quality of life in patients with advanced non-small-cell lung cancer receiving platinum-doublet chemotherapy. Eur J Cancer (2010) 1.13

The effect of comorbidity on stage-specific survival in resected non-small cell lung cancer patients. Eur J Cancer (2012) 1.01

Networking metabolites and diseases. Proc Natl Acad Sci U S A (2008) 1.00

Comorbid diseases interact with breast cancer to affect mortality in the first year after diagnosis--a Danish nationwide matched cohort study. PLoS One (2013) 0.94

A disease module in the interactome explains disease heterogeneity, drug response and captures novel pathways and genes in asthma. Hum Mol Genet (2015) 0.93

A DIseAse MOdule Detection (DIAMOnD) algorithm derived from a systematic analysis of connectivity patterns of disease proteins in the human interactome. PLoS Comput Biol (2015) 0.93

Genetic similarity between cancers and comorbid Mendelian diseases identifies candidate driver genes. Nat Commun (2015) 0.86

Serum levels of interleukin 10 (IL-10) in patients with type 2 diabetes. Iran Red Crescent Med J (2011) 0.83

Online Mendelian Inheritance in Man. Anesthesiology (1998) 0.80

Coexistence of rheumatoid arthritis, ankylosing spondylitis and dermatomyositis in a patient with diabetes mellitus and the associated linked HLA antigens. Br J Rheumatol (1988) 0.80

Ankylosing spondylitis and other inflammatory spondyloarthritis increase the risk of developing type 2 diabetes in an Asian population. Rheumatol Int (2013) 0.77

Articles by these authors

Synteny Portal: a web-based application portal for synteny block analysis. Nucleic Acids Res (2016) 0.75